Evidence map›Paper›PMID 22577014›Full record

ReviewProteomics2012

The development of selected reaction monitoring methods for targeted proteomics via empirical refinement.

Michael S Bereman, Brendan MacLean, Daniela M Tomazela, Daniel C Liebler, Michael J MacCoss

Abstract readReview
In one paragraph

Review in Proteomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Crosslinking mass spectrometry: A link between structural biology and systems biology.Protein science : a publication of the Protein Society · 2021
    Review
  15. Application of Proteomics in Sarcoidosis.American journal of respiratory cell and molecular biology · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael S BeremanDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Brendan MacLean
Daniela M Tomazela
Daniel C Liebler
Michael J MacCoss

Funding

ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Clinical Proteomic Technology Assessment for CancerU24CA126479 · NCI · VANDERBILT UNIVERSITY · PI LIEBLER, DANIEL C · 2006 to 2010
$7.9M
Genetic Regulation of Surfactant DeficiencyR01HL082747 · NHLBI · WASHINGTON UNIVERSITY · PI COLE, FRANCIS SESSIONS · 2007 to 2011
$3.5M
Skyline Targeted Proteomics EnvironmentR01GM103551 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2020
$3.4M
Skyline Targeted Proteomics EnvironmentR01RR032708 · NCRR · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2011 to 2011
$380k
NCI NIH HHS U24 CA126479NCI NIH HHS U24 CA126479-04S2NCRR NIH HHS P41 RR011823NCRR NIH HHS R01 RR032708NHGRI NIH HHS T32 HG000035NHLBI NIH HHS R01 HL082747NIGMS NIH HHS P41 GM103533NIGMS NIH HHS R01 GM103551
6 · The paper itself

Abstract

Software advancements in the last several years have had a significant impact on proteomics from method development to data analysis. Herein, we detail a method, which uses our in-house developed software tool termed Skyline, for empirical refinement of candidate peptides from targeted proteins. The method consists of four main steps from generation of a testable hypothesis, method development, peptide refinement, to peptide validation. The ultimate goal is to identify the best performing peptide in terms of ionization efficiency, reproducibility, specificity, and chromatographic characteristics to monitor as a proxy for protein abundance. It is important to emphasize that this method allows the user to perform this refinement procedure in the sample matrix and organism of interest with the instrumentation available. Finally, the method is demonstrated in a case study to determine the best peptide to monitor the abundance of surfactant protein B in lung aspirates.

Indexed as

SoftwareAmino Acid SequenceCalibrationHumansInfant, NewbornLungMass SpectrometryMolecular Sequence DataPeptidesProteomicsPulmonary Surfactant-Associated Protein BReference StandardsReproducibility of ResultsRespiratory Distress Syndrome, NewbornSensitivity and SpecificityPeptidesPulmonary Surfactant-Associated Protein B

Identifiers

PMID22577014
PMCPMC3643124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.